Hasn't NP stated in CCs and paid interviews that the FDA was fine with the small trial size because we'd dosed over 800 pts in the HIV trials with no SAEs related to LL? I've been under the impression all along that there were no issues with 390 participants for CD12. Why would the FDA approve a trial of this size -- hate to wade back into the conspiracy swamp - unless it's by design to delay our progress for the benefit of BP?